To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.
118th Congress
Introduced Feb 6, 2024
Sponsors
Legislative Progress
Introduced
Introduced
Committee
Passed
Feb 6, 2024
Mr. Carter of Georgia (for himself, Ms. Barragán, Mrs. Harshbarger, …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology